Korean Society for Neuro-Oncology [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.

====== Korean Society for Neuro-Oncology ======
https://www.ksno.or.kr/

The [[Korean Society for Neuro-Oncology]] (KSNO) published guidelines for managing adult [[glioma]] in [[2019]], and the [[National Comprehensive Cancer Network]] and [[European Association of Neuro-Oncology]] published guidelines in September 2021 and March 2021, respectively. However, these guidelines have several different [[recommendation]]s in practice, including tissue management, adjuvant treatment after [[surgical resection]], and salvage treatment for recurrent/progressive gliomas. Currently, the KSNO guideline working group is preparing an updated version of the guideline for managing adult gliomas. In this review, common features have been verified and different points are analyzed. Consequently, this review is expected to be informative and helpful to provide high quality evidence and a strong recommendation level for the establishment of new KSNO guidelines for managing gliomas
((Kim YZ, Kim CY, Lim DH. The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO. Brain Tumor Res Treat. 2022 Apr;10(2):83-93. doi: 10.14791/btrt.2022.0001. PMID: 35545827.)).